Got Pregnant on Mounjaro: What Happens Next

You've just found out you're pregnant, stop Mounjaro today

Picture this: you check the test, your mind races, and then you remember the pen sitting in the fridge door. The first practical step is straightforward, don't take the next dose. Mounjaro is a prescription-only medicine licensed for weight management in adults who are not pregnant, and the clinical guidance is unambiguous: tirzepatide should be discontinued as soon as pregnancy is confirmed.

Your next call should be to your GP or maternity unit. Tell them how many weeks pregnant you believe you are, which dose of Mounjaro you were taking, and when you last injected. They will arrange the appropriate early-pregnancy support and flag the exposure in your notes so your obstetric team has the full picture. If you started treatment through an online service, your prescriber should also be notified so your prescription can be paused or closed. You can reach the nume clinical team through our contact page to let us know.

Stopping is not complicated, but the conversation with your maternity team is. Be as precise as you can about timing.

What the evidence actually says, and where the gaps are

The honest answer is that nobody yet knows exactly what tirzepatide exposure in early human pregnancy means for a developing baby. There are no completed clinical trials in pregnant women, ethically, there couldn't be at this stage of the medicine's development.

What does exist is preclinical (animal) data. The Mounjaro Summary of Product Characteristics, published on the electronic Medicines Compendium, describes findings from animal reproduction studies at doses that produced exposures broadly comparable to human clinical doses; those studies found adverse developmental effects. That is the basis for the guidance that tirzepatide should not be used in pregnancy. It does not mean harm is certain in your individual case, but it means the risk is unquantified and the precautionary position is clear. The NHS tirzepatide medicines page states the medicine is not recommended during pregnancy.

If you became pregnant while using Mounjaro, you are not alone, a medicine that reduces appetite and body weight can, in some people, improve hormonal conditions that previously suppressed ovulation. This is discussed further on our page about whether Mounjaro can affect fertility. Unexpected pregnancies have occurred, and if you want to understand more about what it means to have fallen pregnant while taking Mounjaro, our dedicated page walks through the steps and considerations in detail. The MHRA's pharmacovigilance system continues to collect data on GLP-1 exposures in pregnancy; any outcome, positive or negative, can be reported at yellowcard.mhra.gov.uk.

The contraception question, why this sometimes happens

One reason some people have found themselves pregnant on Mounjaro relates to how the medicine interacts with oral contraceptive pills. Tirzepatide slows gastric emptying, which can reduce how much of an oral pill is absorbed, particularly around the time a new dose is started or increased.

UK guidance (including the NHS England weight-management injections guidance) advises adding a non-oral method such as condoms for the first four weeks of tirzepatide treatment and for four weeks after each dose increase, if you rely on a combined oral contraceptive. If this advice wasn't given or wasn't followed, it may explain how a pregnancy occurred despite apparent contraceptive use. It's worth raising this timeline with your GP so the relevant dates go into your records accurately. Our page on Mounjaro and pregnancy covers the contraception context in more detail.

For semaglutide (Wegovy), the same absolute interruption to pill absorption has not been established, but the guidance to stop either medicine in pregnancy is identical. It's not a small print issue.

Planning ahead: the wash-out period and coming back to treatment

If you were not yet pregnant but are thinking about trying to conceive, the guidance is to stop Mounjaro before attempting conception and allow a wash-out period. The appropriate length of that interval is a prescriber-level discussion, not something to decide from a webpage, because it depends on the dose you were on and your individual circumstances. Our page on tirzepatide and pregnancy outcomes covers this in more detail, as does the broader Mounjaro overview.

The same principle applies to breastfeeding: tirzepatide is not recommended while breastfeeding. Whether trace amounts transfer into breast milk in humans is currently unknown. If you are currently pregnant and want to understand the clinical picture in more detail, our page on using Mounjaro when pregnant brings together the relevant guidance in one place.

If you're in good health after delivery and weaning is complete, weight management with a GLP-1 medicine may be something to revisit with a clinician. When that time comes, starting a free consultation with our prescribers is the right first step, they will review your history, including any pregnancy-related changes, before making any clinical decision. Treatment through nume means a named prescriber, not an automated system, reads your case the same day.